Alcohol
Volume 20, Issue 3 , Pages 285-291 , April 2000

Gamma-hydroxybutyric acid and alcohol-related syndromes

Received 9 July 1998 ,Revised 3 December 1998 ,Accepted 8 January 1999.

References 

  1. Addolorato G, Cibin M, Capristo E, Beghè F, Gessa GL, Stefanini FG, et al. Maintaining abstinence for alcohol with γ-hydroxybutyric acid. Lancet. 1988;951:38
  2. Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, et al. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 1996;31:341–345
  3. Benavides J, Rumigny JF, Bourguignon JJ, Wermuth CG, Mandel P, Maitre M. A high-affinity, Na+-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brain. J Neurochem. 1982;38:1570–1575
  4. Bernasconi R, Laubert J, Marescaux C. Experimental absence seizures (potential role of γ-hydroxybutyric acid and GABAB receptors). J Neural Transm Supp. 1992;35:155–177
  5. Bessman SP, Fishbein BJ. Gamma-hydroxybutyrate, a normal brain metabolite. Nature. 1963;200:1207–1208
  6. Canton, G., Ferri, M., Forza, G., Brambilla, C., Minazzato, L., & Gallimberti, L. (1991). Un questionario per la valutazione del craving alcolico: l'ACS (Alcohol Craving Scale). I Congresso Nazionale SITD Roma.
  7. Carter J, Mofenson H, Caraccio T. Gamma-hydroxybutyrate use (New York and Texas, 1995–1996). Morb Mortal Wkly Rep. 1997;46:281–283
  8. Di Bello MG, Gambassi F, Mugnai L, Masini E, Mannaioni PF. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol-dependent patients. Alcologia. 1995;7:111–118
  9. Fadda F, Argiolas A, Melis MR, De Montis G, Gessa GL. Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone. Life Sci. 1983;32:1471–1477
  10. Fadda F, Colombo G, Mosca E, Gessa GL. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats. Alcohol Alcohol. 1989;24:447–451
  11. Ferrara SD, Tedeschi L, Frison G, Rossi A. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. J Forensic Sci. 1995;40:501–504
  12. Friedman J, Westlake R, Furman R. Grievous bodily harm (gamma-hydroxybutyrate abuse leading to a Werniche-Korsakoff syndrome). Neurology. 1996;46:469–471
  13. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, et al. Gamma-hydroxybutyric acid for the treatment of alcohol withdrawal syndrome. Lancet. 1989;2:787–789
  14. Gallimberti L, Ferrara SD, Gessa GL. Il GHB nel trattamento della dipendenza alcolica. Monograph Series 4. Padova: Addiction Res Foundation Italy; 1992;a
  15. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol dependence (a double blind study). Alcohol Clin Exp Res. 1992;16:673–676b
  16. Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Pirastu R, et al. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacol. 1993;9:77–81
  17. Gallimberti L, Schifano F, Forza G, Miconi L, Ferrara SD. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Neurosci. 1994;244:113–114
  18. Galloway GP, Frederick SL, Staggers FE. Physical dependence on sodium oxybate. Lancet. 1994;343:57
  19. Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate (an emerging drug of abuse that causes physical dependence). Addiction. 1997;92:89–96
  20. Gessa GL, Diana M, Fadda F, Colombo G. Gamma-hydroxybutyric acid (GHB) for the treatment of alcohol dependence. Eur Neuropsychopharmacol. 1993;3:224–225
  21. Gessa GL, Agabio R, Lobina C, Pani ML, Reali R, Colombo G. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 2000;20:271–276
  22. Howard SG, Feigenbaum JJ. Effect of γ-hydroxybutyrate on central dopamine release in vivo. Biochem Pharmacol. 1997;53:103–110
  23. Laborit G, Larcan A, Kind A. Le gamma-hydroxybutyrate en anesthesie neuro-chirurgicale. Neurochirurgie. 1962;8:104–107
  24. Louagie HK, Verstraete AG, De Soete CJ, Baetens DG, Calle PA. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. J Toxicol Clin Toxicol. 1997;35:591–594
  25. Mamelak M, Scharr MB, Woods M. Treatment of narcolepsy and sleep apnea with gamma-hydroxybutyrate (a review of clinical and sleep laboratory findings). Sleep. 1986;9:285–289
  26. Mathivet P, Bernasconi R, De Barry J, Marescaux C, Bittiger H. Binding characteristics of γ-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol. 1997;321:67–75
  27. Takahara J, Yunoki S, Yakushiji W, Yamauchi W, Yamane J. Stimulatory effect of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 1977;44:1014–1017
  28. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB) (a neuroactive drug with abuse potential). J Toxicol Clin Toxicol. 1997;35:581–590
  29. Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L'Hermite-Baleriaux M, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young man. J Clin Invest. 1997;100:745–753
  30. Walter, H., Benda, N., Grunhut, C., Nimmerrichter, A., Mader, R., & Lesch, O. M. (in press). GHB efficacy in the treatment of alcohol withdrawal. Alcohol.

PII: S0741-8329(99)00093-2

Alcohol
Volume 20, Issue 3 , Pages 285-291 , April 2000

Article Tools

* Image Usage & Resolution